Documentos relacionados

1. Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood-brain barrier.
2. Efficacy and safety/tolerability of antipsychotics in the treatment of adult patients with major depressive disorder: a systematic review and meta-analysis.
3. Antipsychotics for schizophrenia spectrum disorders with catatonic symptoms.
4. Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone.
5. The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United Kingdom.
6. The effect of therapeutic drug monitoring of risperidone and aripiprazole on weight gain in children and adolescents: the SPACe 2: STAR (trial) protocol of an international multicentre randomised controlled trial.
7. Factors influencing concentrations of risperidone and 9-hydroxyrisperidone in psychiatric outpatients taking immediate-release formulations of risperidone.
8. Involvement of the TNF-α/SATB2 axis in the induced apoptosis and inhibited autophagy of osteoblasts by the antipsychotic Risperidone.
9. Evidence-Based Use of Atypical Antipsychotics in the Care of Children and Adolescents.
10. Delusional infestation: a retrospective cohort study of 49 patients over a 6-year period.